Antimalarial and Structural Studies of Pyridine-Containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase
详细信息 查看全文
- 作者：Jian Xue ; Jiasheng Diao ; Guobin Cai ; Lisheng Deng ; Baisong Zheng ; Yuan Yao ; Yongcheng Song
- 刊名：ACS Medicinal Chemistry Letters
- 出版年：2013
- 出版时间：February 14, 2013
- 年：2013
- 卷：4
- 期：2
- 页码：278-282
- 全文大小：259K
- 年卷期：v.4,no.2(February 14, 2013)
- ISSN：1948-5875
文摘
1-Deoxy-d-xylulose-5-phosphate reductoisomerase (DXR) in the nonmevalonate isoprene biosynthesis pathway is a target for developing antimalarial drugs. Fosmidomycin, a potent DXR inhibitor, showed safety as well as efficacy against Plasmodium falciparum malaria in clinical trials. On the basis of our previous quantitative structure鈥揳ctivity relationship (QSAR) and crystallographic studies, several novel pyridine-containing fosmidomycin derivatives were designed, synthesized, and found to be highly potent inhibitors of P. falciparum DXR (PfDXR) having Ki values of 1.9鈥?3 nM, with the best one being 11脳 more active than fosmidomycin. These compounds also potently block the proliferation of multidrug resistant P. falciparum with EC50 values as low as 170 nM. A 2.3 脜 crystal structure of PfDXR in complex with one of the inhibitors is reported, showing that the flexible loop of the protein undergoes conformational changes upon ligand binding and a hydrogen bond and favorable hydrophobic interactions between the pyridine group and the PfDXR account for the enhanced activity.